Learn about our services and expertise through case studies and more.
- March 1, 2019: An Updated Method for Analyzing Deuterium Content in Pharmaceuticals
- August 31, 2018: USP 1663 and 1664 – The ABCs of E&L
- July 31, 2018: Syringe Discoloration, Heavy Metals, and ICP-MS: A Case Study
- June 29, 2018: USP 476 – Expanding Regulations on Organic Impurities
- May 31, 2018: Inhalation Device Extractables : A Case Study
- February 27, 2018: Adhesive Impurities in Medical Devices
- January 31, 2018: BPOG and the USP – Mitigating Leachable Risk in Biopharmaceutical Manufacturing
- November 29, 2017: Extractables Study on Microneedle Patches
- September 28, 2017: USP 661.1, USP 661.2, and More! – Untangling the Impact of Plastics on Pharmaceuticals
- August 28, 2017: Extractables and Leachables Study on Packaging for a Liquid and Gel Drug Product
- June 27, 2017: Leachable Determination in a Medical Device
- June 5, 2017: Separation of Co-eluting Impurities